Peoples Bank (Kansas)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$528K Sell
21,916
-46
-0.2% -$1.2K 0.51% 60
2026
Q1
$617K Sell
21,962
-700
-3% -$18.6K 0.62% 56
2025
Q4
$564K Sell
22,662
-385
-2% -$9.71K 0.57% 61
2025
Q3
$587K Sell
23,047
-16,406
-42% -$405K 0.58% 60
2025
Q2
$956K Buy
39,453
+640
+2% +$14.9K 0.64% 49
2025
Q1
$984K Sell
38,813
-1,000
-3% -$26.2K 0.67% 46
2024
Q4
$1.06M Sell
39,813
-816
-2% -$22.1K 0.73% 41
2024
Q3
$1.18M Sell
40,629
-3,358
-8% -$98K 0.79% 37
2024
Q2
$1.23M Buy
43,987
+3,300
+8% +$90.9K 0.96% 34
2024
Q1
$1.13M Sell
40,687
-2,802
-6% -$77.8K 0.88% 36
2023
Q4
$1.25M Buy
43,489
+1,657
+4% +$50.1K 1% 32
2023
Q3
$1.39M Buy
+41,832
New +$1.48M 1.19% 28

Other funds holding PFE

Peoples Bank (Kansas)'s PFE Position: Q2 2026 in Review

Peoples Bank (Kansas) reduced its Pfizer (PFE) stake by 0.21% in Q2 2026, selling an estimated $1.2K and leaving 21,916 shares worth $528K. The position accounts for 0.51% of the portfolio, ranked #60.

Peoples Bank (Kansas) first reported a position in PFE in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.39M in Q3 2023. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Peoples Bank (Kansas) held 21,916 shares of Pfizer worth $528K as of Q2 2026.
  • Peoples Bank (Kansas) sold 46 Pfizer shares in Q2 2026, an estimated $1.2K.
  • Pfizer made up 0.51% of Peoples Bank (Kansas)'s portfolio in Q2 2026, its #60 holding.
  • Peoples Bank (Kansas) first reported a position in Pfizer in Q3 2023 and has held it in 12 quarters since.
  • Peoples Bank (Kansas)'s Pfizer position peaked at $1.39M in Q3 2023.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Peoples Bank (Kansas)'s 13F filing for Q2 2026, filed 10 Jul 2026.